Trials / Completed
CompletedNCT06157450
Pharmacokinetics of ZSP1273 in Elder Participants
A Phase I Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate Pharmacokinetics, Safety and Tolerability of ZSP1273 in Elder Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety, tolerability and PK of ZSP1273 in elder Participants
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ZSP1273 | Participants receive ZSP1273 orally. |
Timeline
- Start date
- 2023-10-11
- Primary completion
- 2023-11-01
- Completion
- 2023-11-17
- First posted
- 2023-12-05
- Last updated
- 2023-12-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06157450. Inclusion in this directory is not an endorsement.